Avient Corp is a global provider of specialized polymer materials, including advanced and sustainable solutions for a wide range of industries. The company focuses on developing innovative products that enhance the performance and sustainability of its customers’ applications, offering a diverse portfolio that includes colorants, additives, and composite solutions. Avient is committed to delivering high-quality, value-added products while also prioritizing environmental responsibility through the development of sustainable materials and processes. The company serves various sectors, including packaging, automotive, consumer goods, and healthcare, helping to drive advancements in material science and engineering. Read More
Avient (NYSE:AVNT) reported first-quarter 2026 adjusted earnings per share of $0.83, modestly ahead of the company’s expectations, as pricing and productivity actions helped offset softer demand in several end markets and rising inflationary pressure.
Chairman, President and Chief Executive Officer
MELBOURNE, Australia and INDIANAPOLIS, April 09, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces two additional Non-Executive Director (NED) appointments, effective May 11, 20261, as part of Board expansion and succession planning:
Avient (AVNT) reported Q3 2025 results, missing revenue and EPS estimates. Despite the miss, shares saw a pre-market gain as investors digest the figures.
Avient Corp (AVNT) reported Q2 2025 revenue of $866.5M, slightly missing estimates, while EPS of $0.80 met expectations. Shares rose 5.8% pre-market despite a recent downtrend.
